8/3/2019 Cytokine Class
1/74
8/3/2019 Cytokine Class
2/74
8/3/2019 Cytokine Class
3/74
http://www.copewithcytokines.de/
http://www.copewithcytokines.de/http://www.copewithcytokines.de/8/3/2019 Cytokine Class
4/74
What are cytokines?
A group of proteins used for communications
between cells
Play role similar to hormones (messengers of the
endocrine system)
Hormones usually act at a distance
Cytokines act locallyDiffer from growth factors that are produced
constitutively, while cytokine production is
carefully regulated
8/3/2019 Cytokine Class
5/74
Cytokine nomenclature
Interleukins (1-35)
Interferons (a,b,...,- g)
TNF superfamily
Chemokines
Others
8/3/2019 Cytokine Class
6/74
Properties of cytokines
Proteins
Low molecular weight
Bind to receptor on either cell which producedit or another cell
Receptor binding triggers a signal
Signal results in altered pattern of geneexpression
8/3/2019 Cytokine Class
7/74
Cytokine -mediated effectsCell growth
Cell differentiation
Cell deathInduce non-responsiveness to othercytokines/cells
Induce responsiveness to othercytokines/cells
Induce secretion of other cytokines
8/3/2019 Cytokine Class
8/74
Cytokines can act in threedifferent manners
Autocrine
Cytokine binds to receptor on cell that
secreted it
Paracrine
Cytokine binds to receptors on near by cells
EndocrineCytokine binds cells in distant parts of the
body
8/3/2019 Cytokine Class
9/74
Cytokine Actions
PleiotropyAct on more than one cell type (INFa/b)
Redundancy
More than one cytokine can do the same thing (IFNa/band IFNg)
SynergyTwo or more cytokines cooperate to produce an effect
that is different or greater than the combined effect of
the two cytokines when functioning separately (IL-12and IL-8)
AntagonismTwo or more cytokines work against each other (IL-4
and IL-12)
8/3/2019 Cytokine Class
10/74
8/3/2019 Cytokine Class
11/74
8/3/2019 Cytokine Class
12/74
8/3/2019 Cytokine Class
13/74
How can non-specific
cytokines act specifically?
Only cells expressing receptors for specific
cytokines can be activated by themMany cytokines have very short half-lives
Only cells in close proximity will be activated
High concentrations of cytokines are needed for
activation
Only cells in close proximity will be activated
May require cell-to cell contact
8/3/2019 Cytokine Class
14/74
Control of cytokine function1. DNA level
cytokine genes are normally switchedoff (ie. inducible)
except for a few where the products require
steady state synthesis eg M- CSF, G-CSF, SCF,
IL-6, Epo.
8/3/2019 Cytokine Class
15/74
Control of cytokine function2. post-transcriptional
mRNA instability There are repeats of a
common consensus octamer at the 3untranslated end of the mRNA which confersinstability -UUAUUUAU-
8/3/2019 Cytokine Class
16/74
Control of cytokine function3. post-secretion
Short half-life in serum eg. TNF = 15min
Soluble cytokine receptors, sTNF-R
IL-1 receptor antagonist (IL-1Ra)
cytokines with opposing actions, growth-promotingand growth-inhibitory actions. eg. TNF alpha/TGFbeta, any CSF/IFN alpha/beta, EGF/TGF alpha
IL-4 / IFN gamma - Th1 and Th2-type T
lymphocyte responses eg. CMI or IgE
8/3/2019 Cytokine Class
17/74
Control of cytokine function4. responding cell
up- and down-regulation of receptors
induction or amplification of inflammation ie. bypro-inflammatory cytokines
eg TNF induces IL-1, and IL-1 induces IL-6.
feedback inhibition. Il-1 induces PGE2 which up-regulates adenylate cyclase which increases theintracellular cAMP and down-regulates theproduction of IL-1 and IL-2. Cortisol is stimulated
as part of the stress response and this directlydown-regulates IL-1 and IL-2.
8/3/2019 Cytokine Class
18/74
8/3/2019 Cytokine Class
19/74
(
8/3/2019 Cytokine Class
20/74
Cytokine receptor familiesImmunoglobulin superfamily receptors
Class I cytokine receptor family (hematopoietin
receptors)Binds most of the cytokines in the immune and
hematopoietin systems
Class II cytokine receptor family (IFN)
TNF receptor familyToll-like receptor family (IL-1)
Chemokine receptor family (GPCR)
8/3/2019 Cytokine Class
21/74
8/3/2019 Cytokine Class
22/74
http://www.nature.com/nri/journ
al/v1/n3/animation/nri1201-
200a swf MEDIA1.html
http://www.nature.com/nri/journal/v1/n3/animation/nri1201-200a_swf_MEDIA1.htmlhttp://www.nature.com/nri/journal/v1/n3/animation/nri1201-200a_swf_MEDIA1.htmlhttp://www.nature.com/nri/journal/v1/n3/animation/nri1201-200a_swf_MEDIA1.htmlhttp://1.ppt/http://1.ppt/http://www.nature.com/nri/journal/v1/n3/animation/nri1201-200a_swf_MEDIA1.htmlhttp://www.nature.com/nri/journal/v1/n3/animation/nri1201-200a_swf_MEDIA1.htmlhttp://www.nature.com/nri/journal/v1/n3/animation/nri1201-200a_swf_MEDIA1.htmlhttp://www.nature.com/nri/journal/v1/n3/animation/nri1201-200a_swf_MEDIA1.html8/3/2019 Cytokine Class
23/74
8/3/2019 Cytokine Class
24/74
8/3/2019 Cytokine Class
25/74
8/3/2019 Cytokine Class
26/74
8/3/2019 Cytokine Class
27/74
8/3/2019 Cytokine Class
28/74
8/3/2019 Cytokine Class
29/74
http://1.ppt/http://1.ppt/8/3/2019 Cytokine Class
30/74
8/3/2019 Cytokine Class
31/74
Interleukins(1)
This nomenclature started in 1979. For this designation
the gene sequence of the protein must be unique.
the protein will have also been cloned (cDNA)
the recombinant protein (eg, rIL-1) shown to havethe same activity as the native purified molecule.
IL-1 can be produced by all nucleated cells, has a widerange of biological activities on many target cell types.
In vivoit induces hypotension, fever, weight loss,neutropoenia and acute phase response.
Main function is as a dendritic cell-derived factor whichspecifically promotes the proliferation of T lymphocytes.
http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/8/3/2019 Cytokine Class
32/74
Interleukins(2)
IL-2is a T-cell-derived cytokine which wasfirst described as a T cell growth factor.Now known to stimulate growth and
differentiation of T, B, NK cells, monocytes,macrophages and oligodendrocytes.
IL-3is a haematopoetic growth factor whichstimulates colony formation of erythroid,megakaryocyte, neutrophil, eosinophil,basophil, mast cell and monocyte lineages.
http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/8/3/2019 Cytokine Class
33/74
Interleukins(3)
IL-4 from T-cells and mast cells and acts on B-cells,T-cells, endothelial cells and fibroblasts. It inducesthe secretion of IgE and IgG4 by B-cells. It sharesthis property with IL-13.
IL-5is a T-cell derived glycoprotein which stimulateseosinophil colony formation and is an eosinophildifferentiation factor.
IL-6 is multifunctional, secreted by lymphoid and non-
lymphoid cells. It regulates B-cell function,haematopoesis and the acute phase response.
http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/8/3/2019 Cytokine Class
34/74
Interleukins(4)
IL-7 is a stromal-cell derived factor for progenitor B-cellsand T-cells. The main lymphocyte population in the thymusresponsive to IL-7 is CD4-ve/CD8-ve. IL-7 also promotesgrowth and differentiation of mature T-cells.
IL-8is an inflammatory cytokine, produced by many celltypes, which functions as a neutrophil chemo-attractant andactivation factor. It also attracts basophils and asubpopulation of lymphocytes. It is a potent angiogenicfactor.
IL-9 enhances the proliferation of T-lymphocytes, mast celllines and erythroid precursors.
http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/8/3/2019 Cytokine Class
35/74
Interleukins(5)
IL-10is secreted by TH0 and TH2 subsets of CD4lymphocytes. It blocks activation of cytokine synthesis byTH1 lymphocytes, activated monocytes and NK cells. Itstimulates or enhances the proliferation of B-cells,thymocytes and mast cells and it co-operates with TGF betato stimulate IgA production by human B-cells. There is ahigh degree of homology between IL-10 and an open readingframe (BCRF1) in the EBV genome. The protein encoded hassome of the activities of IL-10 and has been designated vIL-
10. IL-11 is a growth factor for plasmacytoma and macrophage
progenitors. It is related to IL-6.
http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/8/3/2019 Cytokine Class
36/74
Interleukins(6)
IL-12 is important against intracellular pathogens. Itinduces IFN gamma production by T-cells and NK cells, andenhances NK and ADCC activity. It stimulates theproliferation and differentiation of the TH1 CD4 subset.
IL-13 is secreted by activated T-cells and inhibits theproduction of inflammatory cytokines eg (IL-1b, IL-6, TNFa,IL-8) by LPS-activated monocytes. It induces CD23expression on B cells, and with anti-Ig or anti-CD40 canstimulate the secretion of IgM, IgE, and IgG4.
IL-14 enhances the proliferation of activated B-cells. andinhibits Ig synthesis.
http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/8/3/2019 Cytokine Class
37/74
Interleukins(7)
IL-15 shares properties with IL-2.
IL-16 produced by fibroblasts and epithelial cells, chemo-attractant for CD4+ cells (T cells, macrophages, monocytes,eosinophils).
IL-17 produced by CD4+ lymphocytes and activates theproduction of inflammatory mediators (GM-CSF, IL-1betaand TNF alpha) by synoviocytes in arthritis, andmacrophages.
IL-18 produced by activated macrophages. Can induce Th2-type cytokines alone or can induce IFN-gamma productionand promotes Th1-type immune responses in synergy withIL-12.
http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/8/3/2019 Cytokine Class
38/74
Interleukins(8)
IL-19 IL-10 family member, no function ascribed
IL-20IL-10 family member, regulates participation ofkeratinocytes in inflammation
IL-21 IL-10 family member IL-22 IL-10 family member, produced by activated T cells,
no inhibition of monokines
IL-23 similar to IL-12, produced by activated dendriticcells, stimulates IFN and T memory cell proliferation,
transgenics have multiple organ inflammation, IL-24 IL-10 family member, binds keratinocytes.
http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/8/3/2019 Cytokine Class
39/74
IL-25
Interleukin-25 is a novel cytokine
involved in Th1/Th2 regulation whichpromotes Th2 responses by inducing
cytokines such as IL-4, IL-5 and IL-13
http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/8/3/2019 Cytokine Class
40/74
IL-26
cytokine of the IL-10 family
http://1.ppt/http://1.ppt/http://1.ppt/8/3/2019 Cytokine Class
41/74
IL27 acts in synergy with IL12
IL27 triggers expansion of antigen-
specific naive CD4-positive T cells andpromotes polarization towards a Th1phenotype with expression of gamma-interferon
http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/8/3/2019 Cytokine Class
42/74
IL-28 , IL-29
Interleukin 28 and Interleukin 29 May
Have Therapeutic Value AgainstHepatitis Viruses in Humans
Interleukin 28 and interleukin 29 (IL-28and IL-29) are a recently discovered
family of novel class II cytokinesdistantly related to interferon alphaand interleukin 10 (IL-10).
http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/http://1.ppt/8/3/2019 Cytokine Class
43/74
IL-30
This is the new name of P28 , a subunitof IL27
http://1.ppt/http://1.ppt/http://1.ppt/http://www.copewithcytokines.de/cope.cgi?007405http://www.copewithcytokines.de/cope.cgi?005169http://www.copewithcytokines.de/cope.cgi?005169http://www.copewithcytokines.de/cope.cgi?005169http://www.copewithcytokines.de/cope.cgi?007405http://www.copewithcytokines.de/cope.cgi?0074058/3/2019 Cytokine Class
44/74
IL-31
T cellderived cytokines are important in the developmentof an effective immune response, but when dysregulatedthey can promote disease. Here we identify a four-helixbundle cytokine we have called interleukin 31 (IL-31), whichis preferentially produced by T helper type 2 cells. IL-31
signals through a receptor composed of IL-31 receptor Aand oncostatin M receptor. Expression of IL-31 receptor Aand oncostatin M receptor mRNA was induced in activatedmonocytes, whereas epithelial cells expressed bothmRNAs constitutively. Transgenic mice overexpressing IL-31 developed severe pruritis, alopecia and skin lesions.Furthermore, IL-31 receptor expression was increased indiseased tissues derived from an animal model of airwayhypersensitivity. These data indicate that IL-31 may beinvolved in promoting the dermatitis and epithelialresponses that characterize allergic and non-allergicdiseases.
8/3/2019 Cytokine Class
45/74
1: Immunity. 2005 Jan;22(1):131-42. Related Articles,Links
Interleukin-32: a cytokine and inducer of TNFalpha.
Kim SH, Han SY, Azam T, Yoon DY, Dinarello CA.
Department of Medicine, University of Colorado Health Sciences Center,Denver, CO 80262, USA. [email protected]
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Display&dopt=pubmed_pubmed&from_uid=15664165&tool=ExternalSearchhttp://www.ncbi.nlm.nih.gov/entrez/utils/lofref.fcgi?PrId=3533&uid=15664165&db=PubMed&url=http://www.facultyof1000.com/article/15664165http://www.ncbi.nlm.nih.gov/entrez/utils/lofref.fcgi?PrId=3048&uid=15664165&db=PubMed&url=http://linkinghub.elsevier.com/retrieve/pii/S1074761304003802http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Display&dopt=pubmed_pubmed&from_uid=15664165&tool=ExternalSearch8/3/2019 Cytokine Class
46/74
IL-33, an interleukin-1-like cytokine
IL-33, an interleukin-1-like cytokine that signals viathe IL-1 receptor-related protein ST2 and induces Thelper type 2-associated cytokines.
Schmitz J, Owyang A, Oldham E, Song Y, Murphy E, McClanahan TK,Zurawski G, Moshrefi M, Qin J, Li X, Gorman DM, Bazan JF, Kastelein RA.
Schering-Plough Biopharma (formerly DNAX Research, Inc.), 901 CaliforniaAvenue, Palo Alto, California 94304, USA.
Cytokines of the interleukin-1 (IL-1) family, such as IL-1 alpha/beta and IL-18,have important functions in host defense, immune regulation, and inflammation.Insight into their biological functions has led to novel therapeutic approaches totreat human inflammatory diseases. Within the IL-1 family, IL-1 alpha/beta, IL-1Ra,and IL-18 have been matched to their respective receptor complexes and have
been shown to have distinct biological functions. The most prominent orphan IL-1receptor is ST 2. This receptor has been described as a negative regulator of Toll-like receptor-IL-1 receptor signaling, but it also functions as an important effectormolecule of T helper type 2 responses. We report a member of the IL-1 family, IL-33, which mediates its biological effects via IL-1 receptor ST 2, activates NF-kappaB and MAP kinases, and drives production of T(H)2-associated cytokinesfrom in vitro polarized T(H)2 cells. In vivo, IL-33 induces the expression of IL-4, IL-5, and IL-13 and leads to severe pathological changes in mucosal organs.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&itool=PubMed_Abstract&term=%22Schmitz+J%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&itool=PubMed_Abstract&term=%22Owyang+A%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&itool=PubMed_Abstract&term=%22Oldham+E%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&itool=PubMed_Abstract&term=%22Song+Y%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&itool=PubMed_Abstract&term=%22Murphy+E%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&itool=PubMed_Abstract&term=%22McClanahan+TK%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&itool=PubMed_Abstract&term=%22Zurawski+G%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&itool=PubMed_Abstract&term=%22Moshrefi+M%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&itool=PubMed_Abstract&term=%22Qin+J%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&itool=PubMed_Abstract&term=%22Li+X%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&itool=PubMed_Abstract&term=%22Gorman+DM%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&itool=PubMed_Abstract&term=%22Bazan+JF%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&itool=PubMed_Abstract&term=%22Kastelein+RA%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&itool=PubMed_Abstract&term=%22Kastelein+RA%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&itool=PubMed_Abstract&term=%22Bazan+JF%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&itool=PubMed_Abstract&term=%22Gorman+DM%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&itool=PubMed_Abstract&term=%22Li+X%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&itool=PubMed_Abstract&term=%22Qin+J%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&itool=PubMed_Abstract&term=%22Moshrefi+M%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&itool=PubMed_Abstract&term=%22Zurawski+G%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&itool=PubMed_Abstract&term=%22McClanahan+TK%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&itool=PubMed_Abstract&term=%22Murphy+E%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&itool=PubMed_Abstract&term=%22Song+Y%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&itool=PubMed_Abstract&term=%22Oldham+E%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&itool=PubMed_Abstract&term=%22Owyang+A%22%5BAuthor%5Dhttp://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&itool=PubMed_Abstract&term=%22Schmitz+J%22%5BAuthor%5D8/3/2019 Cytokine Class
47/74
Interleukin-34
Regulation of Myeloid Growth andDifferentiation by a Novel Cytokine,
Interleukin-34 (IL-34), via the CSF-1Receptor
8/3/2019 Cytokine Class
48/74
IL-35
Nature450, 566-569 (22 November 2007)
The inhibitory cytokine IL-35 contributes to regulatory T-cell function.
Eur J Immunol. 2007 Nov;37(11):3021-9
IL-35 is a novel cytokine with therapeutic effects againstcollagen-induced arthritis through the expansion of
regulatory T cells and suppression of Th17 cells.
8/3/2019 Cytokine Class
49/74
8/3/2019 Cytokine Class
50/74
* * *
8/3/2019 Cytokine Class
51/74
8/3/2019 Cytokine Class
52/74
8/3/2019 Cytokine Class
53/74
8/3/2019 Cytokine Class
54/74
8/3/2019 Cytokine Class
55/74
8/3/2019 Cytokine Class
56/74
8/3/2019 Cytokine Class
57/74
2.1 CD4+ T Cell and CD8+ T Cell
8/3/2019 Cytokine Class
58/74
T
CD8
CD4
CD4+
25+
Th1
Tc2
Tc1
Th2
Th3
Tr1Peripheral Tlymphocyte
5-10%
30%
60%
Thymus
Treg
Nature Immunology 6 1069 - 1070 (2005)2.1 CD4+ T Cell
8/3/2019 Cytokine Class
59/74
Nature Immunology6, 1069 - 1070 (2005)TH-17: a giant step from TH1 and TH2
Development of IL-17-producing effector CD4+ T cells (TH-17)by IL-23 is inhibited by IFN- and IL-4.
Immunity 9/3/2006 Top 202.1 CD4+ T Cell
8/3/2019 Cytokine Class
60/74
Th17: An Effector CD4 T Cell Lineagewith Regulatory T Cell Ties
Diversification of CD4 T Cell Lineages
Immunity9/3/2006 Top 20
8/3/2019 Cytokine Class
61/74
* * *
8/3/2019 Cytokine Class
62/74
8/3/2019 Cytokine Class
63/74
8/3/2019 Cytokine Class
64/74
8/3/2019 Cytokine Class
65/74
8/3/2019 Cytokine Class
66/74
8/3/2019 Cytokine Class
67/74
8/3/2019 Cytokine Class
68/74
8/3/2019 Cytokine Class
69/74
8/3/2019 Cytokine Class
70/74
8/3/2019 Cytokine Class
71/74
8/3/2019 Cytokine Class
72/74
Clinical applications
Recombinant cytokines (mAbs)
enough
safety -
Which diseases
auto-immune disease
infectious diseases immuno-deficiencies
malignancy
Clinical Use of
8/3/2019 Cytokine Class
73/74
Interferons a(Roferon, Alferon-N, Intron A) antiviral therapy (chronic Hepatatis B and C), hairycell leukemia.
Interferon b(Betaseron) multiple sclerosis.
G-CSF (Neupogen) supportive treatment for bonemarrow transplantation.
Interferon g(Actimunne) chronic granulomatosis.
Epo (Procrite) kidney disorders.GM-CSF, IFN-g, IL2, TNF all toxic when appliedsystemically.
Clinical Use ofCytokines
8/3/2019 Cytokine Class
74/74
Top Related